Výsledky vyhledávání - "Emma Borrego-Diaz Reyes"

Abstract 485: Modulation of microRNA expression in EGFR-tyrosine kinase inhibitor-resistant non-small cell lung cancer cell lines

Autor: Emma Borrego-Diaz Reyes, Chao H. Huang, Andrew K. Godwin, Hannah Motes, Inamul Haque, Mukut Sharma

Publikováno v: Cancer Research. 78:485-485

Objectives: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are now standard of care in lung cancer patients with EGFR mutation. Invariably, these patients develop resistance and require treatment with another EGFR-TKI or chem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbab4465e863686c8eb29d4da15575c0
https://doi.org/10.1158/1538-7445.am2018-485

Zobrazit plný text záznamu

PS01.33: Change in microRNA Profile in Lung Cancer Cell Treated with Chemotherapy Cisplatin (C), Pemetrexed (P) or PC with Bevacizumab (B)

Autor: Jared Kevern, Emma Borrego-Diaz Reyes, Chao H. Huang, Mukut Sharma, Hannah Motes

Publikováno v: Journal of Thoracic Oncology. 11:S289

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97352a2a215e7dccf47f554c45a9c07f
https://doi.org/10.1016/j.jtho.2016.09.068

Zobrazit plný text záznamu

Abstract 2947: MicroRNA 10b, 27a and 27b are involved in the resistance to treatment with epidermal growth factor tyrosine inhibitor (EGFR-TKI) in EGFR mutant lung cancer cell line

Autor: Emma Borrego-Diaz Reyes, Hannah Montes, Mukut Sharma, Chao H. Huang

Publikováno v: Cancer Research. 76:2947-2947

EGFR TKIs are now standard of care in lung cancer patients with EGFR mutation. Invariably, these patients develop resistance and require treatment with another EGFR TKI or chemotherapy. The gate-keeper mutation T790M is responsible for about 50% of r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa96f0d88ba10c5ec23957077c99a5c8
https://doi.org/10.1158/1538-7445.am2016-2947

Zobrazit plný text záznamu

Abstract 2430: Treatment sequence and molecular biomarker in EGFR mutant lung cancer cells

Autor: Emma Borrego-Diaz Reyes, Chao H. Huang, Peter J. Van Veldhuizen, Jared Kevern, Hannah Motes

Publikováno v: Cancer Research. 75:2430-2430

Introduction Lung cancer is the leading cause of cancer related death in the US. A subset of patients with lung cancer has a mutation in the Epidermal Growth Factor Receptor (EGFR) which makes them extremely responsive to EGFR tyrosine kinase inhibit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3bfe16eae28be74810cc1504e7b90a79
https://doi.org/10.1158/1538-7445.am2015-2430

Zobrazit plný text záznamu

In vitro efficacy of MAGMAS inhibition in prostate cancer

Autor: Emma Borrego-Diaz Reyes, Benjamin C. Powers, Peter J. Van Veldhuizen, Bhaskar C. Das, Boumediene Bouzahzah

Publikováno v: Journal of Clinical Oncology. 32:281-281

281 Background: Prostate cancer is the second most common cancer worldwide in males. The initial treatment in advanced cases is medical or surgical castration. The outlook declines when prostate cancer advances independently, despite the aforemention

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a64db430e9324b2f56da69ecbe27851
https://doi.org/10.1200/jco.2014.32.4_suppl.281

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání